SF
SVB FINANCIAL GROUP (SIVBQ)·Q2 2022 Earnings Summary
Executive Summary
- Q2 2022 EPS was $5.60 on net income of $333M as strong NII and core fee income were more than offset by market-driven investment losses and a sizable reserve build; NIM rose 11 bps QoQ to 2.24% as higher rates slowed premium amortization .
- Client funds declined as VC deployment and exits slowed while portfolio company cash burn hit a high; period-end deposits fell $10.2B QoQ to $187.9B and off-balance sheet funds fell $8.0B to $191.2B .
- Management lowered FY22 outlook (NII growth mid-40s% from low-50s%; average loans high-20s% from mid-30s%; SVB Securities revenue $460–500M from $500–550M) and raised core fee growth to mid-50s% given rate-driven client investment fees; expense growth trimmed to low-20s% ex-merger charges .
- Key catalysts: visibility into deposit stabilization, trajectory of VC deployment/exits, reserve trajectory after the $196M provision (incl. $84M from heavier downside scenario weighting), and further rate hedging that reduces down-rate sensitivity .
What Went Well and What Went Wrong
What Went Well
- Net interest income and margin expanded with rates: NII rose to $1.17B (FTE $1.18B) and NIM to 2.24%, aided by slower premium amortization and higher loan/securities yields .
- Core fee income inflected higher: client investment fees jumped to $83M as fee margin rose with Fed hikes; total core fee income rose to $286M (+24% QoQ) .
- Loan growth resilient: period-end loans up $2.3B QoQ to $71.0B on GFB capital call and Tech/LS/HC borrowing; 91% of average loans were variable-rate, positioning for further rate benefits .
- Management tone on preparedness and pipelines: “We’re stronger and better positioned than at any time in our history to support our clients” (CEO) and “pipelines… are at the strongest level… in history” (President, SVB) .
What Went Wrong
- Client funds outflows and deposit mix pressure: period-end deposits fell 5.1% QoQ; noninterest-bearing share fell to 62.8% and cost of deposits rose to 0.16% as higher rates lifted betas and off→on shifts moderated .
- Market-driven investment/warrant pressure: GAAP net losses on investment securities of $(157)M (non-GAAP net of NCI $(137)M); warrant gains fell to $17M; included a ~$40M downward adjustment for illiquid investments and ~$35M public exposure losses offset elsewhere .
- Credit costs rose from scenario weighting and early stress: provision jumped to $196M (vs. $11M in Q1), including ~$84M from heavier downside weighting; unreserved charge-offs of $20M emerged, mainly in investor-dependent portfolios .
Financial Results
Summary P&L and Balance Metrics
Client Funds and Fee Mix
Investment/Warrant Results
Loans by Class (Period-End)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO (Greg Becker): “We’ve lowered our 2022 outlook to reflect these near-term challenges… It’s really just a question of when, not if our markets will recover… we’re stronger and better positioned than at any time in our history” .
- CFO (Dan Beck) on deposits and outlook: “We’re… looking at… $3–$5B… sequential deposit decline” assuming public markets stay shut and private investment declines 20% in Q3 and Q4; July deposit balances “relatively flat” vs Q2-end .
- Strategy on rates: “We’re still well positioned to the upside… [and] can… dampen the asset sensitivity… we’re sitting at 6.8% asset sensitivity to downgrades” and will use received-fixed swaps and loan floors .
- Pipelines: “Tech and healthcare pipelines… at the strongest level… in history… term sheets issued and signed… first or second highest all time” (President SVB) .
Q&A Highlights
- Deposits/loans visibility: Guidance embeds two further quarters of VC declines and elevated burn; deposit declines modeled at $3–$5B sequentially; July flat so far .
- Investment losses: ~$45M mark-to-market on public exposures; ~$40M reserve on illiquid privates; ~$35M hedged equity loss offset in other income .
- Credit: $20M unreserved charge-offs tied to abrupt funding changes; early/growth-stage portfolios bear higher loss content but are a small share (~2% early-stage) .
- Betas/pricing: Deposit beta trending toward ~60% through cycle; Q2 beta impact amplified by off→on shifts; loan yield beta ~70% now, heading toward 80–90% as floors are exceeded .
- Liquidity/funding: ~$3B/quarter securities cash flows help fund loan growth and deposit outflows; flexibility to pull off-balance sheet funds on balance sheet .
- Hedging intent: No plans to reverse HTM transfers; continued focus on protecting to downside while retaining upside .
Estimates Context
- S&P Global consensus estimates were unavailable for SIVBQ due to missing mapping; therefore, we cannot provide vs. consensus comparisons for Q2 2022 or prior periods. Values retrieved from S&P Global were unavailable due to data mapping limitations.*
Key Takeaways for Investors
- Rate leverage remains a support: variable-rate loan mix (91%) and reduced premium amortization lifted NIM; further hikes can aid NII, though deposit betas/mix will offset part of the upside .
- Balance sheet growth constrained near term by slower VC flows/exits and elevated burn; watch for stabilization in deposit trends and private-market normalization as triggers .
- Credit normalization underway: reserve build reflects heavier downside weighting rather than broad deterioration; early-stage exposure is a small share of loans, but investor-dependent segments warrant scrutiny .
- Securities/warrants are a swing factor: Q2 losses were largely market-driven and partly hedged; continued volatility in public tech and private marks could pressure noninterest income .
- Guidance reset lowers 2H22 expectations but raises core fees and NIM outlook; expense growth trimmed—execution on costs and pipelines is a key alpha lever .
- Strategic positioning intact: expanding SVB Securities and private bank capabilities improves franchise durability; robust client acquisition underpins longer-term growth .
Citations:
Earnings press release and financials:
Q2 2022 earnings call transcript:
Prior calls for context: Q1 2022 ; Q4 2021